Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Sept 24 (Reuters) - ESSA Pharma Inc EPIX.O: ESSA PHARMA INC. AMENDS AGREEMENT WITH XENOTHERAPEUTICS ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE $0.12 PER SHARE ESSA PHARMA INC - CVR REPRESENTS RIGHT TO RECEIVE UP TO $0.14 PER SHARE ESSA PHARMA INC - TO APPLY TO SUPREME COURT TO AMEND INTERIM ORDER ESSA PHARMA INC - ADJOURNS SPECIAL MEETING TO OCTOBER 3, 2025 Source text: ID:nCNW5cfYQa Further company coverage: EPIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xoma Royalty
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM